期刊文献+

Gene chip array for differentiation of mycobacterial species and detection of drug resistance 被引量:9

Gene chip array for differentiation of mycobacterial species and detection of drug resistance
原文传递
导出
摘要 Background Gene chip array can differentiate isolated mycobacterial strains using various mycobacterium specific probes simultaneously. Gene chip array can evaluate drug resistance to isoniazid and rifampin of tuberculosis strains by detecting drug resistance related gene mutation. This technique has great potential for clinical application. We performed a retrospective study to investigate the capability of gene chip array in the rapid differentiation of species and detection of drug resistance in mycobacterium, and to evaluate its clinical efficacy. Methods We selected 39 patients (54 clinical mycobacterium isolates), used gene chip array to identify the species of these isolates and detect drug resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates. Meanwhile, these patients' clinical data were analyzed retrospectively. Results Among these 39 patients whose mycobacterium culture were positive, 32 patients' isolates were identified as Mycobacterium tuberculosis, all of them were clinical infection. Seven patients' isolates were identified as non-tuberculosis mycobacterium. Analyzed with their clinical data, only two patients were considered as clinical infection, both of them were diagnosed as hematogenous disseminated Mycobacterium introceflulare infection. The other five patients' isolates were of no clinical significance; their clinical samples were all respiratory specimens. Clinical manifestations of tuberculosis and non-tuberculous mycobacterial infections were similar. Isoniazid resistance was detected in two tuberculosis patients, while rifampin resistance was detected in one tuberculosis patient; there was another patient whose Mycobacterium tuberculosis isolate was resistant to both isoniazid and rifampin (belongs to multidrug resistance tuberculosis). The fact that this patient did not respond to routine anti-tuberculosis chemotherapy also confirmed this result. Conclusions Gene chip array may be a simple, rapid, and reliable method for the identification of most mycobacterial species and detection of drug resistance in Mycobacterium tuberculosis. It is useful in diagnosis, treatment, and hospital infection control of mycobacterial infections, and it may have a great potential for clinical application. Background Gene chip array can differentiate isolated mycobacterial strains using various mycobacterium specific probes simultaneously. Gene chip array can evaluate drug resistance to isoniazid and rifampin of tuberculosis strains by detecting drug resistance related gene mutation. This technique has great potential for clinical application. We performed a retrospective study to investigate the capability of gene chip array in the rapid differentiation of species and detection of drug resistance in mycobacterium, and to evaluate its clinical efficacy. Methods We selected 39 patients (54 clinical mycobacterium isolates), used gene chip array to identify the species of these isolates and detect drug resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates. Meanwhile, these patients' clinical data were analyzed retrospectively. Results Among these 39 patients whose mycobacterium culture were positive, 32 patients' isolates were identified as Mycobacterium tuberculosis, all of them were clinical infection. Seven patients' isolates were identified as non-tuberculosis mycobacterium. Analyzed with their clinical data, only two patients were considered as clinical infection, both of them were diagnosed as hematogenous disseminated Mycobacterium introceflulare infection. The other five patients' isolates were of no clinical significance; their clinical samples were all respiratory specimens. Clinical manifestations of tuberculosis and non-tuberculous mycobacterial infections were similar. Isoniazid resistance was detected in two tuberculosis patients, while rifampin resistance was detected in one tuberculosis patient; there was another patient whose Mycobacterium tuberculosis isolate was resistant to both isoniazid and rifampin (belongs to multidrug resistance tuberculosis). The fact that this patient did not respond to routine anti-tuberculosis chemotherapy also confirmed this result. Conclusions Gene chip array may be a simple, rapid, and reliable method for the identification of most mycobacterial species and detection of drug resistance in Mycobacterium tuberculosis. It is useful in diagnosis, treatment, and hospital infection control of mycobacterial infections, and it may have a great potential for clinical application.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第18期3292-3297,共6页 中华医学杂志(英文版)
关键词 Mycobacterium tuberculosis gene chip Mycobacterium tuberculosis, gene chip
  • 相关文献

参考文献1

二级参考文献10

  • 1National technic steering group of the epidemiological sampling survey for tuberculosis.Report on fourth national epidemiological sampling survey of tuberculosis[].Chin J Tuberc Resp Dis.2002
  • 2C.Dye,,S.Scheele,,P.Dolin,V.Pathania.Conesensus statement.Global burden of tuberculosis;estimated incidence,prevalence,and mortality by country[].WHO Global Surveillance and Monitoring ProjectJAMA.1999
  • 3.Global tuberculosis control: surveillance, planning, financing[].(WHO/HTM/TB/).2006
  • 4Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update[].Tuberculosis Lung Dis.1998
  • 5van,Embden,JDA,Cave,MD,Crawford,JT,Dale,JW,Eisenach,KD,Gicquel,B,Hermans,P,Martin,C,McAdam,R,Shinnik,TM,Small,PM.Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology[].Journal of Clinical Microbiology.1993
  • 6Mokrousov,I,Bhanu,NV,Suffys,PN,Kadival,GV,Yap,SF,Cho,SN,Jordaan,AM,Narvskaya,O,Singh,UB,Gomes,HM,Lee,H,Kulkarni,SP,Lim,KC,Khan,BK,van,Soolingen,D,Victor,TC,Schouls,LM.Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates[].Journal of Microbiological Methods.2004
  • 7Kamerbeek,J,Schouls,L,Kolk,A,van,Agterveld,M,van,Soolingen,D,Kuijper,S,Bunschoten,A,Molhuizen,H,Shaw,R,Goyal,M,van,Embden,J.Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology[].Journal of Clinical Microbiology.1997
  • 8Werngren J,Hoffner S E.Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate[].Journal of Clinical Microbiology.2003
  • 9Rad,ME,Bifani,P,Martin,C,Kremer,K,Samper,S,Rauzier,J.Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family[].Emerging Infectious Diseases.2003
  • 10Dobner P,Rusch-Gerdes S,Bretzel G,et al.Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isniazid resistance[].International Journal of Tuberculosis and Lung Disease.1997

共引文献38

同被引文献128

引证文献9

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部